Table 1. Clinical information of 5 breast cancer patients.
| Patients | Age | Subtype | Tumor size (mm2) |
Menopause | Birth history | Neo-hormone therapy | Procedure | Pathology | Stage | Recurrence | Status | Follow-up duration (dy) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BC1 | 72 | TNBC | 29 × 15 | post | 3 | - | LtBt | Lobular carcinoma | 2B |
+ (bone metastasis) |
Alive | 614 |
| BC2 | 94 | TNBC | 19 × 10 | post | 4 | - | RtBp | Scirrhous carcinoma | 2A | - | Alive | 359 |
| BC3 | 41 | Luminal A | 20 × 15 | pre | 3 | - | LtBt | Scirrhous carcinoma | 2A | - | Alive | 685 |
| BC4 | 47 | Luminal A | 19 × 10 | post | 0 | - | LtBt | Scirrhous carcinoma | 2A | - | Alive | 703 |
| BC5 | 75 | Luminal A | 15 × 8 | post | 2 |
Aromatase Inhibitor |
LtBt | Scirrhous carcinoma | 2A | - | Alive | 720 |
TNBC: triple-negative breast cancer, Luminal A: luminal A type of breast cancer, Lt: left, Rt: right, Bt: total mastectomy, Bp: partial mastectomy.